Nisha C Kakodkar Radhika Peddinti Morris Kletzel Yufeng Tian Lisa J Guerrero Samir D Undevia David Geary Alexandre Chlenski Qiwei Yang Helen R Salwen Susan L Cohn
10.1002/pbc.22639
Pediatr Blood Cancer
2011 Jan;56(1):164-7.
author_manuscript
https://pubmed.ncbi.nlm.nih.gov/20860039/
Cell Proliferation / drug effects Neuroblastoma / drug therapy Quinoxalines / pharmacology
Cell Proliferation / drug effects Neuroblastoma / drug therapy Quinoxalines / pharmacology Case Reports Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Adolescent Antineoplastic Agents / pharmacology Cell Cycle / drug effects Cell Line, Tumor Fatal Outcome Humans Neoplasm Metastasis Neuroblastoma / pathology Quinoxalines / therapeutic use Treatment Outcome Xenograft Model Antitumor Assays Antineoplastic Agents Quinoxalines XK 469
PMC4116189
20860039
The quinoxaline anti-tumor agent (R+)XK469 inhibits neuroblastoma tumor growth
2011